These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19843896)

  • 1. Lipoprotein(a) measurement and determining risk of myocardial infarction.
    Jones SR; Blumenthal RS
    JAMA; 2009 Oct; 302(15):1645; author reply 1645-6. PubMed ID: 19843896
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoprotein(a) and risk of myocardial infarction--genetic epidemiologic evidence of causality.
    Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
    Scand J Clin Lab Invest; 2011 Apr; 71(2):87-93. PubMed ID: 21231777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a) and risk of myocardial infarction.
    Ritter MM; Geiss HC; Richter WO; Schwandt P
    JAMA; 1994 Apr; 271(14):1077. PubMed ID: 8151842
    [No Abstract]   [Full Text] [Related]  

  • 4. Variation of lipoprotein(a) plasma levels after premature myocardial infarction.
    Goliasch G; Wiesbauer F; Blessberger H; Maurer G; Derfler K; Speidl WS
    Int J Cardiol; 2015; 186():5-6. PubMed ID: 25804454
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipoprotein(a) and risk of myocardial infarction.
    Gaw A
    JAMA; 1994 Apr; 271(14):1077; author reply 1078. PubMed ID: 8151843
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipoprotein(a) risk in women and efficacy of ascorbate.
    Bostom AG
    JAMA; 1994 Oct; 272(15):1169. PubMed ID: 7933344
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipid-lowering therapy after myocardial infarction: the Bavarian Cholesterol Screening Project.
    Richter WO; Schwandt P
    JAMA; 1998 Aug; 280(7):603-4. PubMed ID: 9718050
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipoprotein (a) and lipid levels in young patients with myocardial infarction and their first-degree relatives.
    Giri S; Dwivedi S
    Indian Heart J; 2002; 54(1):110. PubMed ID: 11999082
    [No Abstract]   [Full Text] [Related]  

  • 9. Myocardial infarction in South Asians.
    Rambihar VS
    CMAJ; 2002 Sep; 167(5):454; author reply 454-5. PubMed ID: 12240806
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum lipoprotein(a) concentrations do not change significantly in the immediate seven-day period post myocardial infarction.
    Patel P; Davies T; Madira W; Gupta P
    Ann Clin Biochem; 2015 Jul; 52(Pt 4):502-5. PubMed ID: 25344455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of primary and recurrent acute myocardial infarction from lipoprotein(a)--II.
    De Bono D
    J Am Coll Cardiol; 1997 Mar; 29(4):887-8; author reply 888-9. PubMed ID: 9091538
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of primary and recurrent acute myocardial infarction from lipoprotein(a)--I.
    Enas EA
    J Am Coll Cardiol; 1997 Mar; 29(4):887; author reply 888-9. PubMed ID: 9091537
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipoprotein(a) and silent myocardial ischemia in IDDM.
    Hegele RA; Connelly PW; Armstrong PW; Langer A
    Diabetes Care; 1994 Nov; 17(11):1365-7. PubMed ID: 7821186
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lipoprotein(a): epidemiology and therapeutic approaches].
    Kassner U; Thomas HP; Steinhagen-Thiessen E
    Dtsch Med Wochenschr; 2000 Nov; 125(44):1337-43. PubMed ID: 11109417
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipoprotein (a) and lipid levels in young patients with myocardial infarction and their first-degree relatives.
    Isser HS; Puri VK; Narain VS; Saran RK; Dwivedi SK; Singh S
    Indian Heart J; 2001; 53(4):463-6. PubMed ID: 11759936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dramatic lowering of very high Lp(a) in response to niacin.
    Li M; Saeedi R; Rabkin SW; Frohlich J
    J Clin Lipidol; 2014; 8(4):448-50. PubMed ID: 25110227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipoprotein (a) in offspring of patients with premature myocardial infarction.
    Shah SM; Karira KA; Salahuddin ; Soomro MS; Ghafoor S
    J Pak Med Assoc; 2001 May; 51(5):180-3. PubMed ID: 11467239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the presumptive atherothrombogenic action of lipoprotein(a). Facts and speculations.
    Scanu AM
    Biochem Pharmacol; 1993 Nov; 46(10):1675-80. PubMed ID: 8250952
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial Lp(a) - the underestimated cardiovascular risk factor.
    Mellwig KP
    Clin Res Cardiol Suppl; 2017 Mar; 12(Suppl 1):1. PubMed ID: 28236286
    [No Abstract]   [Full Text] [Related]  

  • 20. Can acipimox reduce serum lipoprotein(a) levels in hemodialyzed patients?
    Mavromatidis K; Fitili C; Sombolos K
    Nephron; 1998; 78(4):489. PubMed ID: 9578077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.